To further test whether CDK6 is a target of miR-34a-5p in NPC cells, we performed the luciferase reporter assays by constructing the wild-type or miR-34a-5p binding-site mutated CDK6 into the psiCHECK-2 vector. Here, CDK6 is linked to nasopharyngeal carcinoma.